NeuroScientific sinks on trial hitch

07/09/2022 - 14:04

Bookmark

Upgrade your subscription to use this feature.

Shares in Clough family-backed NeuroScientific Biopharmaceuticals have plunged after a planned clinical trial for its budding Alzheimer’s treatment was rejected by the Human Research Ethics Committee.

Subscribe to read this article.

Register or login now and receive unlimited access to our award-winning, unbiased and trusted
journalism. Your key to local business, news, insights and data.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options